MEDICINE GUIDE · JAPAN
Approved use, prescription access and safety — explained for people living in or visiting Japan.
Ozempic is a prescription medicine approved in Japan for type 2 diabetes. It is not approved here as a weight-loss medicine. SWIFT Clinic does not currently list Ozempic among its published weight-management medicines. This page explains the Japanese system and does not guarantee a prescription.
Ozempic is a prescription medicine approved in Japan for type 2 diabetes. It is not approved here as a weight-loss medicine. SWIFT Clinic does not currently list Ozempic among its published weight-management medicines. This page explains the Japanese system and does not guarantee a prescription.
| Medicine | Ingredient | Form | Japanese approval |
|---|---|---|---|
| Ozempic | Semaglutide | Weekly injection | Type 2 diabetes |
| Wegovy | Semaglutide | Weekly injection | Obesity under defined criteria |
| Rybelsus | Semaglutide | Daily tablet | Type 2 diabetes |
| Mounjaro | Tirzepatide | Weekly injection | Type 2 diabetes |
Semaglutide can cause nausea, vomiting, diarrhoea, constipation and abdominal discomfort. Serious adverse effects are possible. Hypoglycaemia risk can rise with insulin or certain diabetes medicines. Tell the doctor about your medical history, current medicines, pregnancy plans, pregnancy or breastfeeding. Seek urgent care for severe or persistent abdominal pain, repeated vomiting, dehydration, a serious allergic reaction or rapidly worsening symptoms.
No. Ozempic is a prescription medicine and requires a medical assessment.
No. Ozempic is approved for type 2 diabetes. Wegovy is a separate semaglutide product approved for obesity under defined criteria.
Ozempic is not currently listed among the clinic’s published weight-management medicines. Ask the clinic for the latest information; a consultation never guarantees a named medicine.
Rules vary by medicine, quantity and documentation. Check current guidance from Japan’s Ministry of Health before travel.
Ozempic is a prescription medicine approved in Japan for type 2 diabetes. It is not approved here as a weight-loss medicine. SWIFT Clinic does not currently list Ozempic among its published weight-management medicines. This page explains the Japanese system and does not guarantee a prescription.
